Based on the latest data from Jul 24, 2026, PEN's PEG ratio sits at 0.24. This metric combines a PE of 72.77 with an earnings growth rate of 298.2%. Relative to the 0.14 average from the past 4 quarters, the PEG ratio has surged by 78%.
Looking at the past ten years, PEN's PEG ratio has settled around 3.46 on average. At 0.24, today's PEG ratio sits 93% lower than its historical average. Within the past ten years, the Dec 2018 quarter saw the highest PEG reading at 18.02. At 0.02, the Dec 2023 quarter represented the lowest PEG ratio in this timeframe.
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| 2025 | 0.06 | 68.03 | 1,169.4% |
| 2024 | N/A | 659.67 | -84.8% |
| 2023 | 0.02 | 106.14 | 4,840% |
| 2022 | N/A | N/A | -135.7% |
| 2021 | 15.57 | 2,052.29 | 131.8% |
| 2020 | N/A | N/A | -131.7% |
| 2019 | 0.19 | 118.18 | 631.6% |
| 2018 | 18.02 | 643.16 | 35.7% |
| 2017 | N/A | 672.14 | -71.4% |
| 2016 | 0.29 | 130.2 | 444.4% |
| 2015 | 3.99 | 597.89 | 150% |
| 2014 | N/A | N/A | -185.7% |
| 2013 | N/A | N/A | N/A |
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| Mar 2026 | 0.25 | 74.97 | 298.2% |
| Dec 2025 | 0.06 | 68.03 | 1,169.4% |
| Sep 2025 | 0.16 | 59.89 | 370% |
| Jun 2025 | 0.07 | 67.18 | 905.3% |
| Mar 2025 | N/A | 243.1 | -54.5% |
| Dec 2024 | N/A | 659.67 | -84.8% |
| Sep 2024 | N/A | 215.9 | -15.1% |
| Jun 2024 | N/A | 473.61 | -50% |
| Mar 2024 | 0.07 | 92.22 | 1,323.5% |
| Dec 2023 | 0.02 | 106.14 | 4,840% |
| Sep 2023 | 1.01 | 228.22 | 226.2% |
| Jun 2023 | 1.88 | 452.71 | 240.7% |
| Mar 2023 | 8.65 | 1,639.35 | 189.5% |
| Dec 2022 | N/A | N/A | -135.7% |
| Sep 2022 | N/A | N/A | -192.3% |
When comparing to historical data, PEN's PEG ratio is above the 3-year average, yet it comes in under the 5 and 10-year averages.
Penumbra's PEG of 0.24 is lower than the Healthcare sector and the industry average. In comparison with the Healthcare sector average of 0.53, Penumbra's PEG is 55% lower.
| Stock name | PEG ratio | Market cap |
|---|---|---|
| PEN Penumbra Inc | 0.24 | $12.54B |
| OFIX Orthofix Medical Inc | N/A | $454.74M |
PEN's Jul 24, 2026 PEG ratio comes in at 0.24.
Across the past 3 years, PEN's PEG ratio has centered around 0.23.
Across the past 5 years, PEN's PEG ratio has centered around 2.58.
In the last ten years, PEN's peak PEG ratio of 18.02 occurred in the Dec 2018 quarter.
PEN currently has a PEG ratio 93% below its 10-year average.
The 0.24 PEG ratio for PEN reflects robust earnings growth outpacing the current valuation.
The PEG ratio derives from taking PE and dividing by the rate at which earnings are growing (YoY TTM). As of Jul 24, 2026, Penumbra carries a PE ratio of 72.77. Earnings grew at 298.2% over the TTM period ending Mar 2026. Applying the formula, this yields a PEG ratio of 0.24. PEG RATIO(0.24) = PE RATIO(72.77) / EPS GROWTH(298.2%)
All PEG ratio stats are based on quarterly TTM periods, unless otherwise specified.